Suppr超能文献

姜黄素减弱三硝基苯磺酸通过抑制环氧化酶-2的表达诱导慢性结肠炎。

Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2.

作者信息

Jiang Hua, Deng Chang-Sheng, Zhang Ming, Xia Jian

机构信息

Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Hubei Province, China.

出版信息

World J Gastroenterol. 2006 Jun 28;12(24):3848-53. doi: 10.3748/wjg.v12.i24.3848.

Abstract

AIM

To explore the possible mechanisms of curcumin in rat colitis induced by trinitrobenzene sulfonic (TNBS) acid.

METHODS

Rats with TNBS acid-induced colitis were treated with curcumin (30 mg/kg or 60 mg/kg per day ip). Changes of body weight and histological scores as well as survival rate were evaluated. Leukocyte infiltration was detected by myeloperoxidase (MPO) activity assay. The expression of cyclooxygenase-2 (COX-2) was detected by RT-PCR and Western blot. Inflammation cytokines were determined by RT-PCR. Local concentration of prostaglandin E(2) (PGE(2)) in colon mucosa was determined by ELISA.

RESULTS

Curcumin improved survival rate and histological image, decreased the macroscopic scores and MPO activity. Also curcumin reduced the expression of COX-2 and inflammation cytokines. In addition, treatment with curcumin increased the PGE(2) level.

CONCLUSION

Curcumin has therapeutic effects on TNBS acid-induced colitis, the mechanisms seem to be related to COX-2 inhibition and PGE(2) improvement.

摘要

目的

探讨姜黄素对三硝基苯磺酸(TNBS)诱导的大鼠结肠炎的可能作用机制。

方法

用TNBS诱导大鼠结肠炎,然后用姜黄素(每天腹腔注射30毫克/千克或60毫克/千克)进行治疗。评估体重变化、组织学评分以及存活率。通过髓过氧化物酶(MPO)活性测定检测白细胞浸润情况。通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法检测环氧化酶-2(COX-2)的表达。通过RT-PCR测定炎症细胞因子。用酶联免疫吸附测定法(ELISA)测定结肠黏膜中前列腺素E2(PGE2)的局部浓度。

结果

姜黄素提高了存活率,改善了组织学图像,降低了大体评分和MPO活性。姜黄素还降低了COX-2和炎症细胞因子的表达。此外,姜黄素治疗提高了PGE2水平。

结论

姜黄素对TNBS诱导的结肠炎具有治疗作用,其机制可能与抑制COX-2和提高PGE2水平有关。

相似文献

1
Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2.
World J Gastroenterol. 2006 Jun 28;12(24):3848-53. doi: 10.3748/wjg.v12.i24.3848.
2
Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
Int Immunopharmacol. 2006 Aug;6(8):1233-42. doi: 10.1016/j.intimp.2006.02.013. Epub 2006 Apr 7.
4
Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.
Int Immunopharmacol. 2007 Mar;7(3):333-42. doi: 10.1016/j.intimp.2006.11.006. Epub 2006 Dec 18.
5
Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis.
Acta Pharmacol Sin. 2006 Aug;27(8):1071-7. doi: 10.1111/j.1745-7254.2006.00322.x.
7
Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
Planta Med. 2013 Jan;79(2):102-9. doi: 10.1055/s-0032-1328057. Epub 2012 Dec 18.
9
Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model.
J Ethnopharmacol. 2010 Mar 24;128(2):467-75. doi: 10.1016/j.jep.2010.01.024. Epub 2010 Jan 18.
10
Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis.
World J Gastroenterol. 2011 Sep 28;17(36):4076-89. doi: 10.3748/wjg.v17.i36.4076.

引用本文的文献

3
4
Favourable effects of whey protein on acetic acid-induced ulcerative colitis in a rat model.
Arch Med Sci. 2021 Mar 21;18(6):1617-1625. doi: 10.5114/aoms/105839. eCollection 2022.
6
Probiotics, Prebiotics, and Phytogenic Substances for Optimizing Gut Health in Poultry.
Microorganisms. 2022 Feb 8;10(2):395. doi: 10.3390/microorganisms10020395.
9
and evidence of hypouricemic and anti-inflammatory activities of (Lour.) Corner heartwood extract.
J Tradit Complement Med. 2019 Mar 9;10(1):85-94. doi: 10.1016/j.jtcme.2019.03.003. eCollection 2020 Jan.
10
Phytotherapies in inflammatory bowel disease.
J Res Med Sci. 2019 May 22;24:42. doi: 10.4103/jrms.JRMS_590_17. eCollection 2019.

本文引用的文献

1
Chemopreventive and therapeutic effects of curcumin.
Cancer Lett. 2005 Jun 8;223(2):181-90. doi: 10.1016/j.canlet.2004.09.041. Epub 2004 Nov 11.
2
The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
Inflamm Res. 2005 Apr;54(4):145-51. doi: 10.1007/s00011-004-1337-2.
3
Ischemic colitis associated with rofecoxib.
Dig Liver Dis. 2005 May;37(5):372-6. doi: 10.1016/j.dld.2004.07.020.
4
COX-2: a molecular target for colorectal cancer prevention.
J Clin Oncol. 2005 Apr 20;23(12):2840-55. doi: 10.1200/JCO.2005.09.051.
6
Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.
Pharmacology. 2004 Oct;72(2):77-84. doi: 10.1159/000079135.
7
Inflixmab as a possible treatment for the hemorrhagic type of Crohn's disease.
J Gastroenterol. 2004;39(3):284-7. doi: 10.1007/s00535-003-1290-9.
9
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction.
Gut. 2003 Dec;52(12):1714-20. doi: 10.1136/gut.52.12.1714.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验